BridgeBio Pharma, Inc. (1BBIO)
Market Closed
17 Jul, 15:30
€
72. 66
0
0%
€
11.89B Market Cap
- P/E Ratio
- Div Yield
1 Volume
-3.85 Eps
€ 72.66
Previous Close Want to track 1BBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
BridgeBio Pharma, Inc. (1BBIO) Statistics
Valuation metrics
Market Cap 11.89B
Enterprise value 11.08B
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) 20.07
Price/Book (mrq) -4.76
Enterprise Value/Revenue 22.23
Enterprise Value/EBITDA -25.84
Overview
Shares outstanding 195.71M
Float 162.87M
Shares short -
% Held by insiders 0.04%
% Held by institutions 1.03%
Average volume (10 days) 15
Average volume (90 days) 12
Price summary
52-Week low 36.2
52-Week high 80.42
Beta 1.02
50-Day moving average 59.47
200-Day moving average 55.69
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -1.24%
Operating margin -0.54%
Operational effectiveness
Return on assets -0.28%
Return on equity 0.35%
Income Statement
Revenue (ttm) 498.53M
Revenue per share (ttm) 3.01
Quarterly revenue growth (yoy) 0.67%
Gross profit (ttm) 474.23M
EBITDA -428.83M
Net income to common (ttm) -620.24M
Diluted EPS (ttm) -3.22
Quarterly earnings growth (yoy) 0.67%
Balance Sheet
Total cash (mrq) 808.17M
Total cash per share (mrq) 4.8
Total debt (mrq) 2.14B
Total Debt/Equity (mrq) -0.94
Current ratio (mrq) 1.52%
Book value per share (mrq) -10.01
Cash Flow
Cash flow statement -381.62M
Levered free cash flow (LFCF) -273.27M
